VLP (Virus-Like Particles) Vaccines - Current Knowledge and Future Directions [PDF]
Brazilian Archives of Biology and TechnologyViruses are acellular, potential pathogenic agents causing infections, ranging from acute to chronic. A wide range of conventional immunization methodologies have been employed to control viral diseases. But, their ability to mutate or remain inactive in
Prakash Meghana +2 more
doaj +1 more source
Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections
Frontiers in Immunology, 2018 For many years, the focus of prophylactic vaccines was to elicit neutralizing antibodies, but it has become increasingly evident that T cell-mediated immunity plays a central role in controlling persistent viral infections such as with human ...
Eleni Panagioti +5 more
doaj +1 more source
A Stochastic Model to Assess the Epidemiological Impact of Vaccine Booster Doses on COVID-19 and Viral Hepatitis B Co-Dynamics with Real Data [PDF]
, 2023 Andrew Omame +2 more
openalex +1 more source
The Pan African Medical Journal, 2019 INTRODUCTION: The paucity of data on hepatitis' epidemiology in Menoua Division, West Region, Cameroon, prompted us to assess the prevalence of viral and non-viral hepatitis in this area.
Mathias Kenfack Tsague +5 more
doaj +1 more source
Interferons and hepatitis C virus
Swiss Medical Weekly, 2012 Interferons are not only the first line of defence against viral infections such as hepatitis C virus infections, but they also have important roles during the chronic phase of viral infections.
Markus H. Heim
doaj +1 more source
Global progress, challenges and strategies in eliminating public threat of viral hepatitis
Infectious Diseases of PovertyBackground The problem caused by viral hepatitis is a major public health challenge faced in the past decade, and the global goal of eliminating viral hepatitis by 2030 is still far away.
Sihui Zhang, Fuqiang Cui
doaj +1 more source
Revista Brasileira de Hematologia e Hemoterapia, 2012 OBJECTIVE: To evaluate viral vaccine antibody levels in children with acute lymphoblastic leukemia after chemotherapy and after vaccine booster doses.
Simone Santana Viana +5 more
doaj +1 more source
Eliminating Viral Hepatitis from India and Southeast Asia by 2030: Challenges and Ways Forward
Preventive Medicine: Research & ReviewsThis review was conducted to understand the epidemiology of hepatitis in Southeast Asia, examine the current scenario, and suggest a way forward for elimination. A comprehensive desk review was followed by analysis and interpretation.
Senthilkumar Ramasamy +5 more
doaj +1 more source
Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection [PDF]
Iranian Journal of Basic Medical Sciences, 2016 Chronic hepatitis B is still a major public health issue despite the successful prophylactic vaccination attempts. Chronicity of hepatitis B virus(HBV) is mainly due to its ability to debilitate host's immune system.
Faezeh Ghasemi +3 more
doaj
Interplay of Host and Viral Genetic Variations in Modulating Antibody Responses to Genotype 3a Hepatitis C Virus: Implications for Vaccine Design [PDF]
Wang Zhi-qing +13 more
openalex +2 more sources